NCT00249041View on ClinicalTrials.gov

Enbrel Liquid Immunogenicity Protocol

PHASE3CompletedINTERVENTIONAL

Enrollment

447

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions

Rheumatoid Arthritis

Interventions

DRUG

50 mg Etanercept

50 mg Etanercept liquid injected SC once weekly using prefilled syringes

DRUG

Enbrel liquid

50 mg Etanercept liquid injected SC once weekly using prefilled syringes

Sponsors

Lead Sponsor

Collaborators (1)

Immunex Corporation

All Listed Sponsors

collaborator

Immunex Corporation

INDUSTRY

lead

Amgen

INDUSTRY